NDC 73556-168 – Tavneos
Avacopan 10 mg/1 · Capsule · Oral
Product NDC73556-168
Product details
- Brand name
- Tavneos
- Generic name
- Avacopan
- Labeler
- ChemoCentryx, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA214487
- Marketed since
- October 18, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Complement 5a Receptor Antagonist
Active ingredients
- Avacopan 10 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 73556-168-01 | 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-01) / 180 CAPSULE in 1 BOTTLE, PLASTIC | Oct 18, 2021 |
| 73556-168-02 | 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-02) / 30 CAPSULE in 1 BOTTLE, PLASTIC | Oct 18, 2021 |
| 73556-168-96 sample | 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-96) / 30 CAPSULE in 1 BOTTLE, PLASTIC | Oct 18, 2021 |